A biomanufacturing site is coming to Canada’s Prince Edward Island
Prince Edward Island may be known more to readers of the Anne of Green Gables series of books, but a new effort by the local and national authorities looks to turn the picturesque island into a hub for biomanufacturing and biotech activity.
The governments of Canada and Prince Edward Island are placing a CAN 50 million ($37.4 million) investment into what is being dubbed the BioAccelerator, with the project being spearheaded by Prince Edward Island BioAlliance, a local business organization. According to an email from a PEI BioAlliance spokesperson, both the Canadian government and the local government contributed CAN 25 million ($18.7 million) to the project.
This will be a new 75,000-square-foot biomanufacturing facility, allowing Canadian biotechs to carry out R&D operations as well as build out any manufacturing operations. The site will also provide access to manufacturing training. According to the email from PEI BioAlliance, the site will have expertise from the National Research Council and the Canadian Alliance for Skills and Training in Life Sciences.
The site, located in Charlottetown, plans to have tenants that will include small and medium-sized biotechs at different stages of development from across Canada and even from international locations. However, details on the exact tenants or the number of workers at the site have not been disclosed. The site is expected to be open by 2025.
“The BioAccelerator will provide essential biomanufacturing facilities and services for businesses across the region and beyond, that are critical to business growth and biomanufacturing self-sufficiency for Canada,” said Prince Edward Island BioAlliance CEO Rory Francis in a release.
While the US has been focused on building out its manufacturing, Canada has also been committing to its fair share of projects.
Last year, both Resilience and Moderna committed to projects in the country, while a $580 million new cell and gene therapy manufacturing center for OmniaBio in Hamilton, Ontario started to make progress.
Editors Note: A previous version of this story had misspelled OmniaBio